Lv7
4320 积分 2024-03-08 加入
Development and Mechanistic Evaluation of Cathepsin B‐Activatable Peptide‐Drug Conjugate PROTACs for Targeted Protein Degradation in Malignant Tumors: Advancing Precision Protein Degradation Therapeutics in Oncology
1天前
已完结
AI-Driven Design and Clinical Translation of Nucleotide−Peptide and Peptide−Drug Conjugates
1天前
已完结
From concept to clinic: Cutting-Edge advances steering the next wave of antibody–drug conjugates innovation
8天前
已完结
PSMA-Targeted Small Molecule–Drug Conjugates Based on a Postprolyl Peptidase–Cleavable Linker for the Treatment of Prostate Cancer
12天前
已完结
Azobenzene‐Based Linker Strategy for Selective Activation of Antibody–Drug Conjugates
14天前
已完结
Antibody-drug Conjugate Biomarker Expression in Gestational Trophoblastic Disease: Folate Receptor Alpha, Nectin-4, Trop-2, and Tissue Factor
29天前
已完结
Expression characteristics of clinically relevant antibody–drug conjugate targets in gestational trophoblastic neoplasia
29天前
已完结
Nucleotide metabolic rewiring enables NLRP3 inflammasome hyperactivation in obesity
1个月前
已完结
Development of Dual-Receptor Lysosome-Targeting Chimeras for Protein Degradation
1个月前
已完结
Development of Cysteic Acid-Modified FAP Radioligands for Enhanced Renal Clearance: From Preclinical Optimization to First-in-Human Study
1个月前
已完结
皖公网安备34019202002308
